EN3267

DRUG2 trials

Sponsors

Kyowa Kirin Co., Ltd.

Conditions

CancerPain

Phase 3

Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.

CompletedNCT00262678

Kyowa Kirin Co., Ltd.Cancer, Pain

Start: 2005-12-31End: 2009-01-31Updated: 2009-06-04

Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients

CompletedNCT00263575

Kyowa Kirin Co., Ltd.Cancer, Pain

Start: 2005-12-31End: 2009-01-31Updated: 2024-06-18

Related Papers

Long-term effectiveness and tolerability of sublingual fentanyl orally disintegrating tablet for the treatment of breakthrough cancer pain.

2011-01-0629 citations

Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain.

2009-12-0192 citations